Role of BDNF in central motor structures and motor diseases

Molecular Neurobiology

Volumn 48, Issue 3, 2013, Pages 783-793

  He, Yan Yan ^a   Zhang, Xiao Yang ^a   Yung, Wing Ho ^b   Zhu, Jing Ning ^a   Wang, Jian Jun ^a  

^a NANJING UNIVERSITY   (China)

^b Prince of Wales Hospital   (Hong Kong)

Author keywords

Basal ganglia; BDNF; Cerebellum; Motor diseases; Spinal cord

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN; NEUROTROPHIN RECEPTOR P75; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C;

AMYOTROPHIC LATERAL SCLEROSIS; BASAL GANGLION; BLOOD BRAIN BARRIER; BRAIN CORTEX; CELL DEATH; CELL SURVIVAL; CEREBELLUM; CEREBELLUM CORTEX; CLINICAL TRIAL (TOPIC); CORPUS STRIATUM; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DRUG EFFICACY; DRUG HALF LIFE; EXCITABILITY; EXCITATORY POSTSYNAPTIC POTENTIAL; GENE EXPRESSION; HUMAN; HUNTINGTON CHOREA; INNERVATION; INTRACELLULAR SIGNALING; LEARNING; LOCOMOTION; MOTOR CONTROL; MOTOR COORDINATION; MOTOR CORTEX; MOTOR DYSFUNCTION; MOTOR NEURON DISEASE; NAUSEA AND VOMITING; NERVE CELL; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NEUROMUSCULAR SYNAPSE; NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN PHOSPHORYLATION; PURKINJE CELL; PUTAMEN; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD CELL CULTURE; SPINAL CORD MOTONEURON; SPINAL CORD VENTRAL HORN; SPINOCEREBELLAR DEGENERATION; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS COMPACTA; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTUM;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; ELECTROPHYSIOLOGICAL PHENOMENA; HUMANS; MOTOR NEURON DISEASE; MOTOR NEURONS; SIGNAL TRANSDUCTION;

EID: 84887993953     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8466-y     Document Type: Review

References (97)

1. Barde YA, Edgar D, Thoenen H (1982) Purification of a new neurotrophic factor from mammalian brain. EMBO J 1:549-53
2. Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P et al (1989) Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341:149-52
3. Park H, Poo MM (2013) Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci 14:7-23
4. Binder DK (2004) The role of BDNF in epilepsy and other diseases of the mature nervous system. Adv Exp Med Biol 548:34-56
5. Castren E, Voikar V, Rantamaki T (2007) Role of neurotrophic factors in depression. Curr Opin Pharmacol 7:18-21
6. Zuccato C, Cattaneo E (2009) Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5:311-22
7. Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL et al (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389:856-60
8. Ming GL, Wong ST, Henley J, Yuan XB, Song HJ, Spitzer NC et al (2002) Adaptation in the chemotactic guidance of nerve growth cones. Nature 417:411-8
9. Oppenheim RW, Yin QW, Prevette D, Yan Q (1992) Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature 360:755-7
10. Vavrek R, Girgis J, Tetzlaff W, Hiebert GW, Fouad K (2006) BDNF promotes connections of corticospinal neurons onto spared descending interneurons in spinal cord injured rats. Brain 129:1534-45
11. -/- mice reveals a role for neurotrophins in CNS patterning. Neuron 19:269-81
12. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP et al (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-2
13. Li Y, Yui D, Luikart BW, McKay RM, Rubenstein JL, Parada LF (2012) Conditional ablation of brain-derived neurotrophic factor-TrkB signaling impairs striatal neuron development. Proc Natl Acad Sci U S A 109:15491-6
14. Chao MV, Hempstead BL (1995) p75 and Trk: a two-receptor system. Trends Neurosci 18:321-6
15. Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609-42
16. Ito M (2011) The cerebellum: brain for an implicit self. FT Press Science, Upper Saddle River
17. Ortega F, Perez-Sen R, Morente V, Delicado EG, Miras-Portugal MT (2010) P2X7, NMDA and BDNF receptors converge on GSK3 phosphorylation and cooperate to promote survival in cerebellar granule neurons. Cell Mol Life Sci 67:1723-33
18. Zirrgiebel U, Ohga Y, Carter B, Berninger B, Inagaki N, Thoenen H et al (1995) Characterization of TrkB receptor-mediated signaling pathways in rat cerebellar granule neurons: involvement of protein kinase C in neuronal survival. J Neurochem 65:2241-50
19. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286:1358-62
20. Middleton FA, Strick PL (2000) Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cogn 42:183-200
21. DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-5
22. Lui NP, Chen LW, Yung WH, Chan YS, Yung KK (2012) Endogenous repair by the activation of cell survival signalling cascades during the early stages of rat parkinsonism. PLoS One 7:e51294
23. Bizzi E, Tresch MC, Saltiel P, D'Avella A (2000) New perspectives on spinal motor systems. Nat Rev Neurosci 1:101-8
24. Gao L, Li LH, Xing RX, Ou S, Liu GD, Wang YP et al (2012) Gastrocnemius-derived BDNF promotes motor function recovery in spinal cord transected rats. Growth Factors 30:167-75
25. Hu P, Kalb RG (2003) BDNF heightens the sensitivity of motor neurons to excitotoxic insults through activation of TrkB. J Neurochem 84:1421-30
26. Slack SE, Pezet S, McMahon SB, Thompson SW, Malcangio M (2004) Brain-derived neurotrophic factor induces NMDA receptor subunit one phosphorylation via ERK and PKC in the rat spinal cord. Eur J Neurosci 20:1769-78
27. Roux PP, Barker PA (2002) Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 67:203-33
28. Florez-McClure ML, Linseman DA, Chu CT, Barker PA, Bouchard RJ, Le SS et al (2004) The p75 neurotrophin receptor can induce autophagy and death of cerebellar Purkinje neurons. J Neurosci 24:4498-509
29. Boyce VS, Park J, Gage FH, Mendell LM (2012) Differential effects of brain-derived neurotrophic factor and neurotrophin-3 on hindlimb function in paraplegic rats. Eur J Neurosci 35:221-32
30. Kafitz KW, Rose CR, Thoenen H, Konnerth A (1999) Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 401:918-21
31. Shen RY, Altar CA, Chiodo LA (1994) Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo. Proc Natl Acad Sci U S A 91:8920-4
32. Kleim JA, Chan S, Pringle E, Schallert K, Procaccio V, Jimenez R et al (2006) BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nat Neurosci 9:735-7
33. Fritsch B, Reis J, Martinowich K, Schambra HM, Ji Y, Cohen LG et al (2010) Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning. Neuron 66:198-204
34. Boxall AR (2000) GABAergic mIPSCs in rat cerebellar Purkinje cells are modulated by TrkB and mGluR1-mediated stimulation of Src. J Physiol 524(Pt 3):677-84
35. Huang Y, Ko H, Cheung ZH, Yung KK, Yao T, Wang JJ et al (2012) Dual actions of brain-derived neurotrophic factor on GABAergic transmission in cerebellar Purkinje neurons. Exp Neurol 233:791-8
36. Carter AR, Chen C, Schwartz PM, Segal RA (2002) Brain-derived neurotrophic factor modulates cerebellar plasticity and synaptic ultrastructure. J Neurosci 22:1316-27
37. Jia Y, Gall CM, Lynch G (2010) Presynaptic BDNF promotes postsynaptic long-term potentiation in the dorsal striatum. J Neurosci 30:14440-5
38. Giralt A, Carreton O, Lao-Peregrin C, Martin ED, Alberch J (2011) Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction. Mol Neurodegener 6:71
39. Arvanian VL, Mendell LM (2001) Acute modulation of synaptic transmission to motoneurons by BDNF in the neonatal rat spinal cord. Eur J Neurosci 14:1800-8
40. Lohof AM, Ip NY, Poo MM (1993) Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature 363:350-3
41. McGurk JS, Shim S, Kim JY, Wen Z, Song H, Ming GL (2011) Postsynaptic TRPC1 function contributes to BDNF-induced synaptic potentiation at the developing neuromuscular junction. J Neurosci 31:14754-62
42. Nagahara AH, Tuszynski MH (2011) Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov 10:209-19
43. Moore DH, Katz JS, Miller RG (2011) A review of clinical trial designs in amyotrophic lateral sclerosis. Neurodegenerative Disease Management 1:481-490
44. Cozzolino M, Ferri A, Carri MT (2008) Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications. Antioxid Redox Signal 10:405-43
45. Nishio T, Sunohara N, Furukawa S (1998) Neutrophin switching in spinal motoneurons of amyotrophic lateral sclerosis. Neuroreport 9:1661-5
46. Ekestern E (2004) Neurotrophic factors and amyotrophic lateral sclerosis. Neurodegener Dis 1:88-100
47. Tuszynski MH, Mafong E, Meyer S (1996) Central infusions of brain-derived neurotrophic factor and neurotrophin-4/5, but not nerve growth factor and neurotrophin-3, prevent loss of the cholinergic phenotype in injured adult motor neurons. Neuroscience 71:761-71
48. Mitsumoto H, Ikeda K, Klinkosz B, Cedarbaum JM, Wong V, Lindsay RM (1994) Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 265:1107-10
49. Turner BJ, Cheah IK, Macfarlane KJ, Lopes EC, Petratos S, Langford SJ et al (2003) Antisense peptide nucleic acid-mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice. J Neurochem 87:752-63
50. Zhai J, Zhou W, Li J, Hayworth CR, Zhang L, Misawa H et al (2011) The in vivo contribution of motor neuron TrkB receptors to mutant SOD1 motor neuron disease. Hum Mol Genet 20:4116-31
51. Yanpallewar SU, Barrick CA, Buckley H, Becker J, Tessarollo L (2012) Deletion of the BDNF truncated receptor TrkB.T1 delays disease onset in a mouse model of amyotrophic lateral sclerosis. PLoS One 7:e39946
52. Ochs G, Penn RD, York M, Giess R, Beck M, Tonn J et al (2000) A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:201-6
53. Beck M, Flachenecker P, Magnus T, Giess R, Reiners K, Toyka KV et al (2005) Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF. Amyotroph Lateral Scler Other Motor Neuron Disord 6:100-3
54. Nicaise C, Mitrecic D, Pochet R (2011) Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells. Neuropathol Appl Neurobiol 37:179-88
55. Schols L, Bauer P, Schmidt T, Schulte T, Riess O (2004) Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 3:291-304
56. Takahashi M, Ishikawa K, Sato N, Obayashi M, Niimi Y, Ishiguro T et al (2012) Reduced brain-derived neurotrophic factor (BDNF) mRNA expression and presence of BDNF-immunoreactive granules in the spinocerebellar ataxia type 6 (SCA6) cerebellum. Neuropathology 32:595-603
57. Hourez R, Servais L, Orduz D, Gall D, Millard I, de Kerchove d'Exaerde A et al (2011) Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1. J Neurosci 31:11795-807
58. Dieni S, Rees S (2002) Distribution of brain-derived neurotrophic factor and TrkB receptor proteins in the fetal and postnatal hippocampus and cerebellum of the guinea pig. J Comp Neurol 454:229-40
59. Ringstedt T, Lagercrantz H, Persson H (1993) Expression of members of the trk family in the developing postnatal rat brain. Brain Res Dev Brain Res 72:119-31
60. Furutani K, Okubo Y, Kakizawa S, Iino M (2006) Postsynaptic inositol 1,4,5-trisphosphate signaling maintains presynaptic function of parallel fiber-Purkinje cell synapses via BDNF. Proc Natl Acad Sci U S A 103:8528-33
61. Hisatsune C, Kuroda Y, Akagi T, Torashima T, Hirai H, Hashikawa T et al (2006) Inositol 1,4,5-trisphosphate receptor type 1 in granule cells, not in Purkinje cells, regulates the dendritic morphology of Purkinje cells through brain-derived neurotrophic factor production. J Neurosci 26:10916-24
62. Johnson EM, Craig ET, Yeh HH (2007) TrkB is necessary for pruning at the climbing fibre-Purkinje cell synapse in the developing murine cerebellum. J Physiol 582:629-46
63. Rico B, Xu B, Reichardt LF (2002) TrkB receptor signaling is required for establishment of GABAergic synapses in the cerebellum. Nat Neurosci 5:225-33
64. Jones J, Jaramillo-Merchan J, Bueno C, Pastor D, Viso-Leon M, Martinez S (2010) Mesenchymal stem cells rescue Purkinje cells and improve motor functions in a mouse model of cerebellar ataxia. Neurobiol Dis 40:415-23
65. Ohta H, Arai S, Akita K, Ohta T, Fukuda S (2011) Neurotrophic effects of a cyanine dye via the PI3K-Akt pathway: attenuation of motor discoordination and neurodegeneration in an ataxic animal model. PLoS One 6:e17137
66. Yuan H, Zhang ZW, Liang LW, Shen Q, Wang XD, Ren SM et al (2010) Treatment strategies for Parkinson's disease. Neurosci Bull 26:66-76
67. Marco S, Canudas AM, Canals JM, Gavalda N, Perez-Navarro E, Alberch J (2002) Excitatory amino acids differentially regulate the expression of GDNF, neurturin, and their receptors in the adult rat striatum. Exp Neurol 174:243-52
68. Yan Q, Rosenfeld RD, Matheson CR, Hawkins N, Lopez OT, Bennett L et al (1997) Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system. Neuroscience 78:431-48
69. Baydyuk M, Nguyen MT, Xu B (2011) Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration. Exp Neurol 228:118-25
70. Stahl K, Mylonakou MN, Skare O, Amiry-Moghaddam M, Torp R (2011) Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease. Brain Res 1378:105-18
71. Howells DW, Porritt MJ, Wong JY, Batchelor PE, Kalnins R, Hughes AJ et al (2000) Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp Neurol 166:127-35
72. Scalzo P, Kummer A, Bretas TL, Cardoso F, Teixeira AL (2010) Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease. J Neurol 257:540-5
73. Ziebell M, Khalid U, Klein AB, Aznar S, Thomsen G, Jensen P et al (2012) Striatal dopamine transporter binding correlates with serum BDNF levels in patients with striatal dopaminergic neurodegeneration. Neurobiol Aging 33(428):e1-5
74. Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M et al (2005) BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology 65:1823-5
75. Levivier M, Przedborski S, Bencsics C, Kang UJ (1995) Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci 15:7810-20
76. Tsukahara T, Takeda M, Shimohama S, Ohara O, Hashimoto N (1995) Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced parkinsonism in monkeys. Neurosurgery 37:733-9, discussion 739-741
77. Ferrer I, Goutan E, Marin C, Rey MJ, Ribalta T (2000) Brain-derived neurotrophic factor in Huntington disease. Brain Res 866:257-61
78. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L et al (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293:493-8
79. Baquet ZC, Bickford PC, Jones KR (2005) Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J Neurosci 25:6251-9
80. Reiner A, Wang HB, Del Mar N, Sakata K, Yoo W, Deng YP (2012) BDNF may play a differential role in the protective effect of the mGluR2/3 agonist LY379268 on striatal projection neurons in R6/2 Huntington's disease mice. Brain Res 1473:161-72
81. Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J et al (2010) Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease. Behav Brain Res 214:193-200
82. Hathorn T, Snyder-Keller A, Messer A (2011) Nicotinamide improves motor deficits and upregulates PGC-1alpha and BDNF gene expression in a mouse model of Huntington's disease. Neurobiol Dis 41:43-50
83. Xie Y, Hayden MR, Xu B (2010) BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice. J Neurosci 30:14708-18
84. Borel L, Lopez C, Peruch P, Lacour M (2008) Vestibular syndrome: a change in internal spatial representation. Neurophysiol Clin 38:375-89
85. Lacour M, Tighilet B (2010) Plastic events in the vestibular nuclei during vestibular compensation: the brain orchestration of a "deafferentation" code. Restor Neurol Neurosci 28:19-35
86. Pirvola U, Arumae U, Moshnyakov M, Palgi J, Saarma M, Ylikoski J (1994) Coordinated expression and function of neurotrophins and their receptors in the rat inner ear during target innervation. Hear Res 75:131-44
87. Bianchi LM, Conover JC, Fritzsch B, DeChiara T, Lindsay RM, Yancopoulos GD (1996) Degeneration of vestibular neurons in late embryogenesis of both heterozygous and homozygous BDNF null mutant mice. Development 122:1965-73
88. Montcouquiol ME, Sans NA, Travo C, Sans A, Valat J (2000) Detection and localization of BDNF in vestibular nuclei during the postnatal development of the rat. Neuroreport 11:1401-5
89. Ernfors P, Van De Water T, Loring J, Jaenisch R (1995) Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron 14:1153-64
90. Zheng JL, Stewart RR, Gao WQ (1995) Neurotrophin-4/5, brain-derived neurotrophic factor, and neurotrophin-3 promote survival of cultured vestibular ganglion neurons and protect them against neurotoxicity of ototoxins. J Neurobiol 28:330-40
91. Li YX, Hashimoto T, Tokuyama W, Miyashita Y, Okuno H (2001) Spatiotemporal dynamics of brain-derived neurotrophic factor mRNA induction in the vestibulo-olivary network during vestibular compensation. J Neurosci 21:2738-48
92. Smith PF, Curthoys IS (1989) Mechanisms of recovery following unilateral labyrinthectomy: a review. Brain Res Brain Res Rev 14:155-80
93. Bolger C, Sansom AJ, Smith PF, Darlington CL (1999) An antisense oligonucleotide to brain-derived neurotrophic factor delays postural compensation following unilateral labyrinthectomy in guinea pig. Neuroreport 10:1485-8
94. Maingay MG, Sansom AJ, Kerr DR, Smith PF, Darlington CL (2000) The effects of intra-vestibular nucleus administration of brain-derived neurotrophic factor (BDNF) on recovery from peripheral vestibular damage in guinea pig. Neuroreport 11:2429-32
95. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L et al (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290:767-73
96. Gasmi M, Brandon EP, Herzog CD, Wilson A, Bishop KM, Hofer EK et al (2007) AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's disease. Neurobiol Dis 27:67-76
97. O'Leary PD, Hughes RA (2003) Design of potent peptide mimetics of brain-derived neurotrophic factor. J Biol Chem 278:25738-44